tridecanoic acid
Small moleculeexperimental
Tridecylic acid, or tridecanoic acid, is the organic compound with the formula CH3(CH2)11CO2H. It is a 13-carbon saturated fatty acid. It is a white solid. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2017 (NCT03059160)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- excipientOTHER
excipient other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTridecylic acid ↗
Also known as
- tridecanoic acid
- tridecanoic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03059160 | Phase 2 | Apr 1, 2017 | Tel Aviv University, Ultragenyx Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Ultragenyx Inc. | For profit | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1